KLK3 and obesity due to melanocortin 4 receptor deficiency: We conducted a case–control study nested within the PSA-testing phase of the Prostate testing for cancer and Treatment (ProtecT) study (Donovan et al, 2002) to examine associations of obesity with screen-detected prostate cancer.